• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脉络丛作为 Alzheimer 病和唐氏综合征痴呆中 TREM2、载脂蛋白 E 异常积聚和纤维状 Tau 的守门员。

Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia.

机构信息

Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, Cambridge, UK.

John van Geest Centre for Brain Repair, Department of Clinical Neuroscience, University of Cambridge, Cambridge, UK.

出版信息

J Alzheimers Dis. 2019;69(1):91-109. doi: 10.3233/JAD-181179.

DOI:10.3233/JAD-181179
PMID:30909239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6598012/
Abstract

BACKGROUND

Genetic factors that influence Alzheimer's disease (AD) risk include mutations in TREM2 and allelic variants of Apolipoprotein E, influencing AD pathology in the general population and in Down syndrome (DS). Evidence shows that dysfunction of the choroid plexus may compromise the blood-cerebrospinal fluid (CSF) barrier, altering secretary, transport and immune function that can affect AD pathology.

OBJECTIVE

To investigate the genotype and phenotype of DS individuals in relation to choroid plexus damage and blood-CSF barrier leakage to identify markers that could facilitate early diagnosis of AD in DS.

METHODS

To assess allele frequency and haplotype associations ApoE, Tau, TREM2, and HLA-DR were analyzed by SNP analysis in DS participants (n = 47) and controls (n = 50). The corresponding plasma protein levels were measured by ELISA. Postmortem brains from DS, AD, and age-matched controls were analyzed by immunohistochemistry.

RESULTS

Haplotype analysis showed that individuals with Tau H1/H1 and ApoEɛ4 genotypes were more prevalent among DS participants with an earlier diagnosis of dementia (17%) compared to H1/H2 haplotypes (6%). Plasma TREM2 levels decreased whereas phospho-tau levels increased with age in DS. In AD and DS brain, insoluble tau and ApoE were found to accumulate in the choroid plexus.

CONCLUSION

Accumulation of tau and ApoE in the choroid plexus may increase the oligomerization rate of Aβ42 and impair tau trafficking, leading to AD pathology. We have identified a high-risk haplotype: ApoEɛ4, Tau/H1, and TREM2/T, that manifests age-related changes potentially opening a window for treatment many years prior to the manifestation of the AD dementia.

摘要

背景

影响阿尔茨海默病(AD)风险的遗传因素包括 TREM2 突变和载脂蛋白 E 的等位基因变体,影响一般人群和唐氏综合征(DS)中的 AD 病理学。有证据表明,脉络丛功能障碍可能会损害血脑屏障,改变分泌、转运和免疫功能,从而影响 AD 病理学。

目的

研究与脉络丛损伤和血脑屏障渗漏相关的 DS 个体的基因型和表型,以确定有助于早期诊断 DS 中 AD 的标志物。

方法

通过 SNP 分析评估 DS 参与者(n=47)和对照组(n=50)中 ApoE、Tau、TREM2 和 HLA-DR 的等位基因频率和单倍型关联。通过 ELISA 测量相应的血浆蛋白水平。通过免疫组织化学分析 DS、AD 和年龄匹配对照的死后大脑。

结果

单倍型分析显示,与 H1/H2 单倍型(6%)相比,具有 Tau H1/H1 和 ApoEɛ4 基因型的个体在具有早期痴呆诊断的 DS 参与者中更为常见(17%)。DS 中 TREM2 水平随年龄降低,磷酸化 tau 水平升高。在 AD 和 DS 大脑中,发现不溶性 tau 和 ApoE 在脉络丛中积累。

结论

tau 和 ApoE 在脉络丛中的积累可能会增加 Aβ42 的寡聚化速度并损害 tau 转运,从而导致 AD 病理学。我们已经确定了一种高风险单倍型:ApoEɛ4、Tau/H1 和 TREM2/T,其表现出与年龄相关的变化,可能在 AD 痴呆症表现之前多年就为治疗开辟了一个窗口。

相似文献

1
Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia.脉络丛作为 Alzheimer 病和唐氏综合征痴呆中 TREM2、载脂蛋白 E 异常积聚和纤维状 Tau 的守门员。
J Alzheimers Dis. 2019;69(1):91-109. doi: 10.3233/JAD-181179.
2
The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.载脂蛋白 E 和 TREM2 在阿尔茨海默病中的作用:当前的认识和观点。
Int J Mol Sci. 2018 Dec 26;20(1):81. doi: 10.3390/ijms20010081.
3
Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.红细胞-髓系衍生触发受体 2:唐氏综合征阿尔茨海默病病理的主要决定因素。
J Alzheimers Dis. 2018;61(3):1143-1162. doi: 10.3233/JAD-170814.
4
Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease.纵向基底前脑退化与阿尔茨海默病前症状期的 TREM2/C3 炎症生物标志物相互作用。
J Neurosci. 2020 Feb 26;40(9):1931-1942. doi: 10.1523/JNEUROSCI.1184-19.2019. Epub 2020 Jan 8.
5
Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.TREM2 在阿尔茨海默病中的作用及其对β-淀粉样蛋白、tau 和神经原纤维缠结的影响。
Curr Alzheimer Res. 2019;16(13):1216-1229. doi: 10.2174/1567205016666190903102822.
6
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.载脂蛋白 E 基因型与阿尔茨海默病脑脊液生物标志物的诊断准确性。
JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.
7
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.阿尔茨海默病患者脑脊液中可溶性触发受体表达分子2(TREM2)浓度升高。
Mol Neurodegener. 2016 Jan 12;11:3. doi: 10.1186/s13024-016-0071-x.
8
TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.TREM2改变小胶质细胞表型并为P301S tau转基因小鼠提供神经保护。
Neuropharmacology. 2016 Jun;105:196-206. doi: 10.1016/j.neuropharm.2016.01.028. Epub 2016 Jan 21.
9
The extended tau haplotype and the age of onset of dementia in Down syndrome.唐氏综合征中延长的tau单倍型与痴呆症的发病年龄
Dement Geriatr Cogn Disord. 2008;26(3):199-202. doi: 10.1159/000152044. Epub 2008 Sep 3.
10
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.唐氏综合征和散发性阿尔茨海默病中的淀粉样蛋白、tau 和细胞因子的血浆生物标志物。
Alzheimers Res Ther. 2019 Mar 21;11(1):26. doi: 10.1186/s13195-019-0477-0.

引用本文的文献

1
Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer's disease.阿尔茨海默病小鼠模型脉络丛中的早期转录和细胞异常。
Mol Neurodegener. 2025 May 31;20(1):62. doi: 10.1186/s13024-025-00853-w.
2
Blood-based biomarkers for Alzheimer's disease in Down syndrome: A systematic review and meta-analysis.唐氏综合征中阿尔茨海默病的血液生物标志物:系统评价与荟萃分析
Alzheimers Dement. 2025 Apr;21(4):e70135. doi: 10.1002/alz.70135.
3
Choroid plexus cysts on 7T MRI: Relationship to aging and neurodegenerative diseases.

本文引用的文献

1
Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.红细胞-髓系衍生触发受体 2:唐氏综合征阿尔茨海默病病理的主要决定因素。
J Alzheimers Dis. 2018;61(3):1143-1162. doi: 10.3233/JAD-170814.
2
Increased levels of plasma total tau in adult Down syndrome.成年唐氏综合征患者血浆总tau蛋白水平升高。
PLoS One. 2017 Nov 30;12(11):e0188802. doi: 10.1371/journal.pone.0188802. eCollection 2017.
3
Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome.
7T磁共振成像上的脉络丛囊肿:与衰老和神经退行性疾病的关系
Alzheimers Dement. 2025 Feb;21(2):e14484. doi: 10.1002/alz.14484. Epub 2024 Dec 28.
4
Choroid Plexus Pathophysiology.脉络丛病理生理学
Annu Rev Pathol. 2025 Jan;20(1):193-220. doi: 10.1146/annurev-pathmechdis-051222-114051. Epub 2025 Jan 2.
5
Associations between the choroid plexus and tau in Alzheimer's disease using an active learning segmentation pipeline.利用主动学习分割管道研究阿尔茨海默病脉络丛和 tau 之间的关系。
Fluids Barriers CNS. 2024 Jul 12;21(1):56. doi: 10.1186/s12987-024-00554-4.
6
Decoding sTREM2: its impact on Alzheimer's disease - a comprehensive review of mechanisms and implications.解读可溶性触发受体2(sTREM2):其对阿尔茨海默病的影响——机制与意义的全面综述
Front Aging Neurosci. 2024 Jun 7;16:1420731. doi: 10.3389/fnagi.2024.1420731. eCollection 2024.
7
Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.在实验系统中增加淀粉样蛋白-β脑外排的方法。
J Alzheimers Dis. 2024;100(2):379-411. doi: 10.3233/JAD-240212.
8
Association of soluble TREM2 with Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis.可溶性触发受体表达于髓样细胞2(TREM2)与阿尔茨海默病及轻度认知障碍的关联:一项系统评价和荟萃分析。
Front Aging Neurosci. 2024 May 22;16:1407980. doi: 10.3389/fnagi.2024.1407980. eCollection 2024.
9
Spatial transcriptomic brain imaging reveals the effects of immunomodulation therapy on specific regional brain cells in a mouse dementia model.空间转录组学脑成像揭示了免疫调节疗法对小鼠痴呆模型特定区域脑细胞的影响。
BMC Genomics. 2024 May 25;25(1):516. doi: 10.1186/s12864-024-10434-8.
10
Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology.MS4A 簇中的变异与可溶性 TREM2 表达相互作用,影响神经病理学生物标志物。
Mol Neurodegener. 2024 May 18;19(1):41. doi: 10.1186/s13024-024-00727-7.
定量检测血浆磷酸化 tau 作为脑内阿尔茨海默病病理标志物的研究:包括阿尔茨海默病患者和唐氏综合征患者的初步病例对照研究。
Mol Neurodegener. 2017 Sep 4;12(1):63. doi: 10.1186/s13024-017-0206-8.
4
The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis.存在和不存在纤维状β-淀粉样变性的唐氏综合征大脑。
Neurobiol Aging. 2017 May;53:11-19. doi: 10.1016/j.neurobiolaging.2017.01.009. Epub 2017 Jan 17.
5
Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.触发受体表达于髓样细胞2(TREM-2)在衰老和阿尔茨海默病模型中的神经保护作用。
J Alzheimers Dis. 2017;55(1):199-217. doi: 10.3233/JAD-160663.
6
TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia.TREM2 与载脂蛋白结合,包括 APOE 和 CLU/APOJ,从而促进小胶质细胞摄取淀粉样β。
Neuron. 2016 Jul 20;91(2):328-40. doi: 10.1016/j.neuron.2016.06.015.
7
TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance.触发受体表达分子2(TREM2)缺陷会降低免疫治疗性淀粉样蛋白清除的疗效。
EMBO Mol Med. 2016 Sep 1;8(9):992-1004. doi: 10.15252/emmm.201606370. Print 2016 Sep.
8
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis.TREM2 变体:解析阿尔茨海默病发病机制的新钥匙。
Nat Rev Neurosci. 2016 Apr;17(4):201-7. doi: 10.1038/nrn.2016.7. Epub 2016 Feb 25.
9
The Choroid Plexus in Healthy and Diseased Brain.健康与患病大脑中的脉络丛
J Neuropathol Exp Neurol. 2016 Mar;75(3):198-213. doi: 10.1093/jnen/nlv030. Epub 2016 Feb 17.
10
TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.TREM2改变小胶质细胞表型并为P301S tau转基因小鼠提供神经保护。
Neuropharmacology. 2016 Jun;105:196-206. doi: 10.1016/j.neuropharm.2016.01.028. Epub 2016 Jan 21.